» Articles » PMID: 32575987

Interaction with Human Serum Proteins Reveals Biocompatibility of Phosphocholine-Functionalized SPIONs and Formation of Albumin-Decorated Nanoparticles

Overview
Journal Langmuir
Specialty Chemistry
Date 2020 Jun 25
PMID 32575987
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Nanoparticles (NPs) are increasingly exploited as diagnostic and therapeutic devices in medicine. Among them, superparamagnetic nanoparticles (SPIONs) represent very promising tools for magnetic resonance imaging, local heaters for hyperthermia, and nanoplatforms for multimodal imaging and theranostics. However, the use of NPs, including SPIONs, in medicine presents several issues: first, the encounter with the biological world and proteins in particular. Indeed, nanoparticles can suffer from protein adsorption, which can affect NP functionality and biocompatibility. In this respect, we have investigated the interaction of small SPIONs covered by an amphiphilic double layer of oleic acid/oleylamine and 1-octadecanoyl--glycero-3-phosphocholine with two abundant human plasma proteins, human serum albumin (HSA) and human transferrin. By means of spectroscopic and scattering techniques, we analyzed the effect of SPIONs on protein structure and the binding affinities, and only found strong binding in the case of HSA. In no case did SPIONs alter the protein structure significantly. We structurally characterized HSA/SPIONs complexes by means of light and neutron scattering, highlighting the formation of a monolayer of protein molecules on the NP surface. Their interaction with lipid bilayers mimicking biological membranes was investigated by means of neutron reflectivity. We show that HSA/SPIONs do not affect lipid bilayer features and could be further exploited as a nanoplatform for future applications. Overall, our findings point toward a high biocompatibility of phosphocholine-decorated SPIONs and support their use in nanomedicine.

Citing Articles

Emerging prospects of protein/peptide-based nanoassemblies for drug delivery and vaccine development.

Liu T, Li L, Cheng C, He B, Jiang T Nano Res. 2022; 15(8):7267-7285.

PMID: 35692441 PMC: 9166156. DOI: 10.1007/s12274-022-4385-4.


A Tri-Stimuli Responsive (Maghemite/PLGA)/Chitosan Nanostructure with Promising Applications in Lung Cancer.

Fernandez-Alvarez F, Garcia-Garcia G, Arias J Pharmaceutics. 2021; 13(8).

PMID: 34452193 PMC: 8401782. DOI: 10.3390/pharmaceutics13081232.


Towards the Development of Antioxidant Cerium Oxide Nanoparticles for Biomedical Applications: Controlling the Properties by Tuning Synthesis Conditions.

Gallucci N, Vitiello G, Di Girolamo R, Imbimbo P, Monti D, Tarallo O Nanomaterials (Basel). 2021; 11(2).

PMID: 33672757 PMC: 7924622. DOI: 10.3390/nano11020542.

References
1.
Montis C, Generini V, Boccalini G, Bergese P, Bani D, Berti D . Model lipid bilayers mimic non-specific interactions of gold nanoparticles with macrophage plasma membranes. J Colloid Interface Sci. 2018; 516:284-294. DOI: 10.1016/j.jcis.2018.01.064. View

2.
Luchini A, Heenan R, Paduano L, Vitiello G . Functionalized SPIONs: the surfactant nature modulates the self-assembly and cluster formation. Phys Chem Chem Phys. 2016; 18(27):18441-9. DOI: 10.1039/c6cp01694d. View

3.
Wolfram J, Yang Y, Shen J, Moten A, Chen C, Shen H . The nano-plasma interface: Implications of the protein corona. Colloids Surf B Biointerfaces. 2014; 124:17-24. PMC: 4152388. DOI: 10.1016/j.colsurfb.2014.02.035. View

4.
Chi Z, Liu R, Teng Y, Fang X, Gao C . Binding of oxytetracycline to bovine serum albumin: spectroscopic and molecular modeling investigations. J Agric Food Chem. 2010; 58(18):10262-9. DOI: 10.1021/jf101417w. View

5.
Dominguez-Medina S, Kisley L, Tauzin L, Hoggard A, Shuang B, Indrasekara A . Adsorption and Unfolding of a Single Protein Triggers Nanoparticle Aggregation. ACS Nano. 2016; 10(2):2103-12. PMC: 4768289. DOI: 10.1021/acsnano.5b06439. View